Metis Global Partners, LLC Eli Lilly & CO Transaction History

Metis Global Partners, LLC

$3.16 Billion
Q3 2024

A detailed history of Metis Global Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Metis Global Partners, LLC holds 47,210 shares of LLY stock, worth $36.2 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

47,210

Previous 46,102 2.4%

Holding current value

$36.2 Million

Previous $41.7 Million 0.21%

% of portfolio

1.33%

Previous 1.45%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $855,531 - $1.06 Million	1,108 Added 2.4%	47,210 $41.8 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $160,921 - $201,806	-222 Reduced 0.48%	46,102 $41.7 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $63,365 - $84,773	107 Added 0.23%	46,324 $36 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $2.8 Million - $3.3 Million	5,332 Added 13.04%	46,217 $26.9 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $2.41 Million - $3.32 Million	5,544 Added 15.69%	40,885 $22 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $563,288 - $753,181	1,606 Added 4.76%	35,341 $16.6 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $2.6 Million - $3.06 Million	8,383 Added 33.07%	33,735 $11.6 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $3.24 Million - $3.78 Million	10,076 Added 65.96%	25,352 $9.27 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $485,041 - $552,755	1,636 Added 11.99%	15,276 $4.94 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $227,164 - $266,725	815 Added 6.35%	13,640 $4.42 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $1.24 Million - $1.55 Million	5,299 Added 70.41%	12,825 $3.67 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $1.69 Million - $2.1 Million	7,526 New	7,526 $2.08 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Account

Metis Global Partners, LLC Eli Lilly & CO Transaction History